ClinicalTrials.Veeva

Menu

Management of Mixed-Phenotype Acute Leukemia in the East of France (ELABEST)

C

Central Hospital, Nancy, France

Status

Unknown

Conditions

Mixed Phenotype Acute Leukemia

Study type

Observational

Funder types

Other

Identifiers

NCT03599869
PSS2017/ELABEST-BONMATI/VS

Details and patient eligibility

About

Clinical presentation and management of Mixed-Phenotype Acute leukemia (MPAL) is heterogeneous. This descriptive observationnal study aims to review MPAL cases in the East of France based on a 10-year multicentre retrospective collection.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Adult patients over 18 years of age
  • Diagnosis of biphenotypic acute leukemia or mixed-phenotype acute leukemia between 2008 and 2018

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems